Clinical Trials Logo

Gulf War Illness clinical trials

View clinical trials related to Gulf War Illness.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02011542 Terminated - Gulf War Illness Clinical Trials

Probiotic (VSL #3) for Gulf War Illness

Start date: September 2013
Phase: Phase 2/Phase 3
Study type: Interventional

The overall objective is to determine whether VSL #3 will improve 1) intestinal symptoms of Irritable Bowel Syndrome (IBS) and 2) non-intestinal symptoms (fatigue, joint pain, insomnia, general stiffness and headache) associated with IBS. All of these symptoms are part of the Gulf War (GW) illness.

NCT ID: NCT01846182 Terminated - Gulf War Illness Clinical Trials

Research Examining Gulf War Illness in Our Nations Service Members

REGIONS
Start date: June 24, 2015
Phase: Phase 2
Study type: Interventional

At least 1 in 4 of the 700,000 U.S. Veterans who served in the 1990-1991 Gulf War suffer from Gulf War Illness (GWI). Despite considerable research, effective treatments remain elusive. GWI refers to a complex of symptoms that typically include widespread chronic pain, persistent headache, memory and concentration problems, gastrointestinal difficulties, sleep disturbances and unexplained fatigue. These symptoms are similar to that of fibromyalgia syndrome (FMS), another multi-symptom condition. Whereas, effective treatments for GWI have yet to be found, the FDA has approved duloxetine and pregabalin for the treatment of FMS. The lack of progress in finding effective treatments for GWI, and the similarities between GWI and FMS, provides a rationale for determining if these medications can provide relief to Veterans who suffer from GWI. This randomized controlled trial will test the efficacy of Duloxetine and Pregabalin for treating Gulf War Veterans who suffer from GWI.